Over the past two decades, GLP-1 RAs have become a cornerstone in the treatment algorithm for T2DM, especially in patients who require improved glycaemic control with the added benefit of weight reduction and cardiovascular protection. Here, GLP1R is linked to type 2 diabetes mellitus.